Siemens to acquire Corindus Vascular Robotics for $1.1B in cash
Siemens Healthineers is shelling out $1.1B in cash for Corindus Vascular Robotics, maker of a minimally invasive platform for coronary, peripheral, and neurovascular procedures. Siemens will acquire all issued and outstanding shares of Corindus’ common stock for $4.28 per share. The merger is expected to close by the end of the year.
This deal will combine Siemens’ surgery tools in digital imaging and artificial intelligence with a precision robotics platform for cardiovascular disease.
